Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
SK networks seeks to promote blockchain business through joint efforts with Hashed 2022-02-04 16:51
Splitit survey shows most prefer a Buy Now, Pay Later option on existing credit cards vs. a new line of credit 2022-02-04 09:43
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine 2022-02-04 06:54
USANA's Malaysia and Korea markets start 2022 with major honors 2022-02-04 03:00
Greenland Technologies Chooses Cyngn to Bring Autonomous Vehicle Technology to Their Fleet of Lithium-Powered Electric Forklifts 2022-02-03 21:00
Color Star Technology Co., Ltd. (NASDAQ: CSCW) Announces that Dubai Education Center Joins Color World, Bringing Online Education Services for Users Globally 2022-02-03 20:00
Ucommune Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency 2022-02-03 19:30
Maxeon Solar Technologies Extends the Product, Power and Service Warranty on its Flagship Product Line to 40 Years 2022-02-03 19:05
China Liberal Education Holdings Limited Enters into Definitive Agreement to Acquire Wanwang Investment Limited 2022-02-03 17:00
Xiaomi Strengthens Data Protection with Independent Audit of Compliance 2022-02-03 12:05
Clarity advances to cohort 2 in the SARTATE™ neuroblastoma trial 2022-02-01 21:58
Color Star Technology Co., Ltd. (NASDAQ: CSCW) Announces that Thai Construction Company, The Jade to Join Color World, with Smart Technology Opening Up New Possibilities for Real Estate Companies 2022-02-01 20:00
Senmiao Technology Receives Capacity Star Award of Chengdu from Meituan 2022-01-31 22:00
Recon Announces RMB6.87 Million Metering Instrument Maintenance Contract with a Refining and Chemical Company 2022-01-31 21:30
Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement 2022-01-31 19:00
ARV partners with IBM to build a national digital corporate identity system for Thailand's standardized corporate onboarding process 2022-01-31 13:01
AKESO'S LIGUFALIMAB AND IVONESCIMAB OBTAINED APPROVAL TO INITIATE A PHASE II TRIAL 2022-01-31 10:14
AKESO DOSES FIRST PATIENT IN THE PHASE III TRIAL OF IVONESCIMAB COMBINED WITH CHEMOTHERAPY IN EGFR-TKI RESISTANT EGFR MUTATION ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER 2022-01-31 09:51
Tencent Music Unveils Recent Global Accolades for Music Industry Support and Cultural Exchange 2022-01-30 14:36
Boqii Holding Limited Receives NYSE Non-Compliance Letter Regarding ADS Trading Price 2022-01-29 18:00
1 654 655 656 657 658 2444